I was thinking back on Amag, they had a so so product, absolutely horrible balance sheet, but had great backing. Do I remember their stock being 60+ when they got FDA approval? They still have a horrible company balance sheet but their stock is @ 47. The one thing that they apparently didn't have was Rockwell's group of short players. What a shame.